Can psychedelic compounds play a part in drug dependence therapy?

Research output: Contribution to journalReview articlepeer-review

Abstract

After a 40-year hiatus there is now a revisiting of psychedelic drug therapy throughout psychiatry, with studies examining the drugs psilocybin, ketamine, ibogaine and ayahuasca in the treatment of drug dependence. Limitations to these therapies are both clinical and legal, but the possibility of improving outcomes for patients with substance dependency imposes an obligation to research this area.

Original languageEnglish (US)
Pages (from-to)1-3
Number of pages3
JournalBritish Journal of Psychiatry
Volume206
Issue number1
DOIs
StatePublished - Jan 1 2015

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Can psychedelic compounds play a part in drug dependence therapy?'. Together they form a unique fingerprint.

Cite this